Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, B-Cell 1

Interventions

Cytarabine 19Cyclophosphamide 18venetoclax 15fludarabine phosphate 14Busulfan 14Cyclosporine 12Azacitidine 11fludarabine 10Peripheral Blood Stem Cell Transplantation 10Granulocyte Colony-Stimulating Factor 10Mycophenolic Acid 9Filgrastim 9Melphalan 8Antilymphocyte Serum 8Whole-Body Irradiation 7Palliative Care 7Idarubicin 6Blood Specimen Collection 6Methotrexate 5Therapeutics 4Specimen Handling 4Radiotherapy 4Methods 4Early Intervention, Educational 4Daunorubicin 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Tacrolimus 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myeloid, Acute × Immunotherapy, Adoptive × Clear all
NCT04692948 2021-03-08

TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Phase NA Unknown
5 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡